ROBERT B WILLIAMS
Nursing at 21 Ter, Gainesville, FL

License number
Florida 9383462
Issued Date
Jun 2, 2014
Effective Date
Jun 2, 2014
Expiration Date
Apr 30, 2018
Category
Health Care
Type
Registered Nurse
Address
Address
4006 NW 21St Ter, Gainesville, FL 32605
Phone
(352) 316-6324

Professional information

Robert Williams Photo 1

Beauty Advisor At Saks Fifth Avenue

Position:
Beauty Advisor at Saks Fifth Avenue
Location:
Gainesville, Florida Area
Industry:
Retail
Work:
Saks Fifth Avenue - Beauty Advisor


Robert Williams Photo 2

Robert Williams, Leesburg FL

Work:
Women S Health-Medical Plaza
601 E Dixie Ave, Leesburg, FL 34748 Shands at AGH
1600 Sw Archer Rd, Gainesville, FL 32610 University of Florida
3951 NW 48Th Ter, Gainesville, FL 32606 Women S Health-Medical Plaza
2000 SW Archer Rd, Gainesville, FL 32608


Robert Williams Photo 3

Robert Williams - Gainesville, FL

Work:
WCJB- TV20 NEWS - Gainesville, FL
Community Service Manager, Promotions Manager, News Anchor
GENERAL MOTORS - Flint, MI
Customer Service and Sales Manager
Education:
General Motors Institute - Flint, MI
Bachelor's in Business/Industrial Administration


Robert Louis Williams Jr. Photo 4

Robert Louis Williams Jr., Gainesville FL - Lawyer

Address:
PO Box 141542, Gainesville 32614
(352) 374-8494
Licenses:
Florida - Member in Good Standing 1978
Education:
University of Memphis - Cecil C. Humphreys School of LawDegree JD - Juris Doctor - Law


Robert Williams Photo 5

Detecting And Treating Reproductive Tract Disorders

US Patent:
7049069, May 23, 2006
Filed:
Jul 17, 2002
Appl. No.:
10/198306
Inventors:
Nasser Chegini - Gainesville FL, US
Robert Stanford Williams - Gainesville FL, US
Barry Ripps - Pensacola FL, US
Assignee:
University of Florida - Gainesville FL
International Classification:
C12Q 1/68, G01N 33/53
US Classification:
435 6, 435 795
Abstract:
Methods for detecting and treating a female reproductive tract disorder relate to the discovery that IL-13 and IL-15 are differentially expressed in biological samples from subjects suffering from a reproductive tract disorder compared to samples from healthy subjects. A female reproductive tract disorder is detected by providing a biological sample derived from the subject; analyzing the expression of IL-13 and/or IL-15 in the sample; and correlating the expression of the cytokine with the presence or absence of the female reproductive tract disorder in the subject. Cytokine expression is modulated in female reproductive tract tissue by contacting the tissue with an agent that modulates expression of IL-13 and/or IL-15 in the tissue.